These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29563295)

  • 1. Intracellular Hepatitis C Virus Modeling Predicts Infection Dynamics and Viral Protein Mechanisms.
    Aunins TR; Marsh KA; Subramanya G; Uprichard SL; Perelson AS; Chatterjee A
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.
    Tellinghuisen TL; Foss KL; Treadaway J
    PLoS Pathog; 2008 Mar; 4(3):e1000032. PubMed ID: 18369478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein.
    Vogt DA; Camus G; Herker E; Webster BR; Tsou CL; Greene WC; Yen TS; Ott M
    PLoS Pathog; 2013; 9(4):e1003302. PubMed ID: 23593007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
    Ikeda M; Yi M; Li K; Lemon SM
    J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortactin Interacts with Hepatitis C Virus Core and NS5A Proteins: Implications for Virion Assembly.
    Nguyen LP; Nguyen TTT; Nguyen HC; Pham HT; Han KM; Choi DH; Park EM; Kang SM; Tark D; Lim YS; Hwang SB
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32727880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein kinase I-α in infectious virus production.
    Masaki T; Matsunaga S; Takahashi H; Nakashima K; Kimura Y; Ito M; Matsuda M; Murayama A; Kato T; Hirano H; Endo Y; Lemon SM; Wakita T; Sawasaki T; Suzuki T
    J Virol; 2014 Jul; 88(13):7541-55. PubMed ID: 24760886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
    Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
    Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus Proteins Core and NS5A Are Highly Sensitive to Oxidative Stress-Induced Degradation after eIF2α/ATF4 Pathway Activation.
    Ríos-Ocampo WA; Navas MC; Buist-Homan M; Faber KN; Daemen T; Moshage H
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32283772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle.
    Murakami Y; Fukasawa M; Kaneko Y; Suzuki T; Wakita T; Fukazawa H
    Microbes Infect; 2013 Jan; 15(1):45-55. PubMed ID: 23103222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production.
    Lin CC; Tsai P; Sun HY; Hsu MC; Lee JC; Wu IC; Tsao CW; Chang TT; Young KC
    J Hepatol; 2014 Nov; 61(5):984-93. PubMed ID: 24996046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Replication of the subgenomic hepatitis C virus replicon in the presence of the NS3 protease inhibitors: a stochastic model].
    Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Samsonova MG; Samsonov AM; Kolchanov NA; Ivanisenko VA
    Biofizika; 2013; 58(5):758-74. PubMed ID: 25481944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.
    Wang WT; Tsai TY; Chao CH; Lai BY; Wu Lee YH
    J Virol; 2015 Nov; 89(22):11584-602. PubMed ID: 26355086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
    Schult P; Nattermann M; Lauber C; Seitz S; Lohmann V
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
    Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
    J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.
    Paul D; Hoppe S; Saher G; Krijnse-Locker J; Bartenschlager R
    J Virol; 2013 Oct; 87(19):10612-27. PubMed ID: 23885072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Hepatitis C Virus Replication PDE Models within a Realistic Intracellular Geometric Environment.
    Knodel MM; Targett-Adams P; Grillo A; Herrmann E; Wittum G
    Int J Environ Res Public Health; 2019 Feb; 16(3):. PubMed ID: 30759770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly.
    Appel N; Zayas M; Miller S; Krijnse-Locker J; Schaller T; Friebe P; Kallis S; Engel U; Bartenschlager R
    PLoS Pathog; 2008 Mar; 4(3):e1000035. PubMed ID: 18369481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life.
    Guedj J; Dahari H; Rong L; Sansone ND; Nettles RE; Cotler SJ; Layden TJ; Uprichard SL; Perelson AS
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3991-6. PubMed ID: 23431163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.